Because Expertise Matters
Join Cyberounds®, an online education community for health professionals Sign Up

Log In

Psychiatry/Neuroscience

The Management of Major Depression During Pregnancy

The treatment of major depressive disorder during pregnancy is complicated by the fact that few studies have been conducted on whether clinical care should differ during pregnancy or what the long-term effects may be on the developing fetus.
CME credit is no longer available for this conference.

Course Authors

Jennifer L. Payne, M.D.

Dr. Payne is Associate Professor of Psychiatry and Director, Women's Mood Disorders Center, Johns Hopkins School of Medicine, Baltimore, MD.

Within the past 12 months, Dr. Payne has been a consultant to AstraZeneca and Pfizer.

Off-label uses of medications will be discussed throughout this Cyberounds.

Release Date: 07/01/2012

 
Learning Objectives

Upon completion of this Cyberounds®, you should be able to:

  • List two known risks to the baby of not treating a major depressive episode during pregnancy

  • Identify two potential risks to the baby of the use of serotonin reuptake inhibitors during the third trimester

  • Apply the risk factors that should be taken into account when deciding on a clinical plan for the management of major depression during pregnancy.

 

TERMS AND CONDITIONS

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms.

Courses You Might Like

Emerging Research on the Use of Psychedelics in the Treatment of Mental Illness

In the last 30 years, revived interest in the application of psychedelic compounds in psychiatry has created a huge body of scientific knowledge on the pharmacological and therapeutic action of these compounds. these compounds.
Authors: Danilo De Gregorio, PharmD, Ph.D.
View Course
More

The Impact of COVID-19 on Mental Health

COVID-19 and the pandemic greatly affected mental health.
Authors: Roger Ho M.D., F.R.C.Psych., F.R.C.P.C., and Cyrus Ho M.B.B.S., M.R.C.Psych.
View Course
More

Molecular Mechanisms of Cognitive Deficits in Schizophrenia

Treatment of the cognitive symptoms of schizophrenia has been the focus of much research because they are highly predictive of long-term functional outcome.
Authors: Sarah Canetta, Ph.D., and Christoph Kellendonk, Ph.D.
View Course
More

PTSD: Current Therapies

Psychological trauma, defined as threat to life or integrity of yourself or someone close to you, affects over half of the U.S. population at some time in their lives.
Authors: J. Douglas Bremner, M.D.
View Course
More

Current and Emerging Therapies for Relapsing-Remitting Multiple Sclerosis

No other area of neurology has seen such a remarkable explosion of new drugs.
Authors: Aaron Miller, M.D..
View Course
More

Glial Cells

Glia are involved in nearly every aspect of brain function, including brain development, homeostasis, information processing, neurological disease and psychiatric illness.
Authors: R. Douglas Fields, Ph.D.
View Course
More